(S1 (FRAG (NP (JJ Doc_816141_0_11_Chemical-induced) (JJ immune) (NN Doc_816141_27_43_Disease)) (. .)))
(S1 (S (NP (NP (DT A) (NN patient)) (PP (IN with) (NP (NNP Doc_816141_60_73_Disease)))) (VP (VBD developed) (NP (JJ Coombs-positive) (NN Doc_816141_100_116_Disease)) (SBAR (IN while) (S (VP (VBG receiving) (NP (JJ Doc_816141_133_144_Chemical) (NN therapy)))))) (. .)))
(S1 (S (NP (DT An) (JJ anti-Doc_816141_162_173_Chemical) (NNP IgG) (NN antibody)) (VP (AUX was) (VP (VBN detected) (PP (PP (IN in) (NP (NP (DT the) (NN patient) (POS 's)) (NN serum))) (CC and) (PP (IN in) (NP (NP (DT the) (NNS eluates)) (PP (IN from) (NP (PRP$ her) (NNS erythrocytes)))))))) (. .)))
(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NP (JJ nonimmunologic) (VBG binding)) (PP (IN of) (NP (JJ normal)))) (CC and) (NP (NP (NP (NN patient) (POS 's)) (JJ serum) (NNS proteins)) (PP (TO to) (NP (PRP$ her) (ADJP (JJ own) (CC and) (JJ Doc_816141_355_366_Chemical-coated)) (JJ normal) (JJ red) (NNS cells))))) (VP (AUX was) (VP (VBN demonstrated))) (. .)))
(S1 (S (NP (NP (NN Skin) (NNS tests)) (CC and) (NP (ADJP (IN in) (NN vitro)) (NN lymphocyte) (NN stimulation))) (VP (VBD revealed) (SBAR (IN that) (S (NP (DT the) (NN patient)) (VP (AUX was) (VP (VBN sensitized) (PP (PP (TO to) (NP (NNP Doc_816141_500_511_Chemical))) (CC and) (PP (ADVP (RB also)) (TO to) (NP (NNP Doc_816141_524_534_Chemical))))))))) (. .)))
(S1 (S (NP (NP (JJ Careful) (NN investigation)) (PP (IN of) (NP (JJ drug-induced) (NNP Doc_816141_574_591_Disease)))) (VP (VBZ reveals) (NP (NP (DT the) (NN complexity)) (PP (IN of) (NP (NP (DT the) (JJ immune) (NNS mechanisms)) (VP (VBN involved)))))) (. .)))
